Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms. Li H, Luo N, Fan C, Han T, et al. BMC Cancer 2025;25:1007.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li H, Luo N, Fan C, Han T, et al. Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms. BMC Cancer 2025;25:1007.
PMID: 40474207